India's Pharmaceutical Exports

Country Profile

Sri Lanka

Sri Lanka is a major destination for Indian pharmaceutical exports — $318M in FY 2025–26, with 2.0× growth over the past decade. Medicines accounts for 86% of shipments, with vaccines contributing $4.50M. The compound annual growth rate since FY2015 stands at 6.4%.

🇱🇰 #19 Destination · $318M · 2.0× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$318M
Exports FY2025–26 DGCIS
2.0×
Growth FY2015→2026
1.0%
Share of India Total
#19
Rank Among 178 Markets
6.4%
CAGR FY2015→2026
Sri Lanka is a major destination for Indian pharmaceutical exports — $318M in FY 2025–26, with 2.0× growth over the past decade. Medicines accounts for 86% of shipments, with vaccines contributing $4.50M. The compound annual growth rate since FY2015 stands at 6.4%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $274M (86.1%) Medicine Ingredients $23.4M (7.4%) Surgical & Hospital Supplies $12.4M (3.9%) Vaccines $4.50M (1.4%) Traditional & Herbal $3.98M (1.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Sri Lanka in the RBI overseas direct investment dataset (2011–2026).